NTL TeleCervico

medical devices

About

Since founded in 1996, NTL has grown to be a leader in the field of cervical cancer screening. In 2004, NTL has developed the remote cervical cancer screening system, TeleCervico® for the first time in the world and has been supplying it for hospitals and clinics. This system represents a breakthrough in cervical cancer examination as it makes the existing off-line examination possible on line using Internet. Based on the technology and know-how accumulated in the service of cervical cancer examination for the last 14 years and continuous challenging spirit, NTL will take the initiative in global cervical cancer screening market by integrating all the cervical cancer-related examinations and strengthening precision control. NTL is presented the thesis of the excellent clinical effects of TeleCervico® to ASCCP(American Society of Colposcopy & Cervical Pathology) and to FIGO and selected as the Korean World-class Product by the Government

Technologies

Mobile Friendly reCAPTCHA Apache WordPress.org Google Maps Google Font API

Keywords

medical device remote cervical cancer screening system cervical cancer examination medical medical equipment manufacturing ai system big data medical device export medical equipment medical image transmission medical system security healthcare it telecervico system medical technology cervical image analysis healthcare data management medical waste reduction clinical diagnostics medical image analysis digital health solutions b2b system quality control healthcare innovation automatic evaluation system integration clinical laboratory big data analytics artificial intelligence medical device r&d women's health

Location

Seoul, South Korea

Related Companies

Companies in the same industry